Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CEP152 antisense RNA 1 (CEP152-AS1)
- Target
- CEP152-AS1
- Molecular classification
- Other (long non-coding RNA, lncRNA)
01
Overview
CEP152 antisense RNA 1 (CEP152-AS1) is a long non-coding RNA gene transcribed from the genomic locus antisense to the coding gene CEP152, which encodes a centrosomal protein involved in centriole duplication. The biological function, mechanistic roles, and disease relevance of CEP152-AS1 have not been well-characterized in the scientific literature. Unlike the protein-coding CEP152 gene, for which there are established roles in cell division and disease, notably primary microcephaly, there are currently no clinical, therapeutic, or biomarker applications attributed to the antisense CEP152-AS1 transcript. No interacting drugs, disease roles, or established biological functions have been reported for this lncRNA. It does not fall into established classes such as receptor, enzyme, transporter, ion channel, or transcription factor, and is not considered a validated therapeutic target.
- Other names
- lncCEP152-AS1long non-coding RNA CEP152-AS1
02
Biological functions
Other (Potential roles in gene expression regulation at the RNA level; little experimentally validated functional annotation available for CEP152-AS1 specifically)
03
Disease associations
Other (No validated disease association or established role in pathology reported for CEP152-AS1 itself; its parental gene, CEP152, is involved in microcephaly, but this is not documented for the lncRNA antisense)
Beyond the preview
Go deeper on CEP152 antisense RNA 1 (CEP152-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CEP152 antisense RNA 1 (CEP152-AS1).